HomeAI · summaries
Storia in 3 fonti
European Regulator Validates Pfizer and Valneva's Lyme Disease Vaccine Application - Pfizer (NYSE:PFE), V
Valneva (VALN) stock surges after EMA validates MAA for Lyme disease vaccine candidate developed with Pfizer (PFE). Phase 3 trial showed efficacy and no safety concerns, pending regulatory approval.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency
Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency
- ·
ilsole24ore.com
Valneva vola a Parigi, vaccino Lyme supera primo step procedurale Ema
L'agenzia ha convalidato la domanda di autorizzazione all'immissione in commercio e avvierà la valutazione della domanda
